Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
AWARENESS Trial (AWARENESS) of Storytelling Through Music in Healthcare Workers
- Status
- COMPLETED
- Phase
- NA
CBCT-Guided Navigational Bronchoscopy For Lung Nodules
- Status
- TERMINATED
- Phase
- NA
Abemaciclib With or Without Atezolizumab for mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
- Status
- RECRUITING
- Phase
- NA
Sacituzumab Govitecan Plus EV in Metastatic UC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Taking AIM at Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Feasibility of Fasting & Exercise in Pts With HR+ MBC
- Status
- COMPLETED
- Phase
- NA
Sargramostim (GM-CSF) + PD-1
- Status
- WITHDRAWN
- Phase
- PHASE2
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Digitally Enhanced Smoking Cessation for High Risk Smokers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
IS-free Treg HaploHCT
- Status
- RECRUITING
- Phase
- PHASE1
Resilience and Equity in Aging, Cancer, and Health (REACH)
- Status
- RECRUITING
- Phase
- NA
Cabozantinib With Topotecan-Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE1
Advance Care Planning: Communicating With Outpatients for Vital Informed Decision
- Status
- COMPLETED
- Phase
- N/A
Refining Local-Regional Therapy for IBC
- Status
- RECRUITING
- Phase
- NA
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1